Bernardo Llovera - BioRem Independent Chairman of the Board
BRM Stock | CAD 2.08 0.07 3.48% |
Chairman
Mr. Bernardo H. Llovera B.A. Dip. MBA. serves as Independent Chairman of the Board of Biorem Inc.Mr. Llovera joined Expansion Capital Partners in 2003 and was a General Partner since January 2004. Mr. Llovera has 10 years of investment management experience primarily in expansion stage VC. Mr. Llovera joined GE Equity in 1996 and from 2000 to 2003 he was Senior Vice President the private investment arm of the General Electric Company where he headed the Enterprise Solutions Group and coheaded the Telecommunications Group. since 2012.
Tenure | 12 years |
Address | 7496 Wellington Road 34, Puslinch, ON, Canada, N0B 2J0 |
Phone | 519-767-9100 |
Web | https://www.biorem.biz |
BioRem Management Efficiency
The company has return on total asset (ROA) of 0.0861 % which means that it generated a profit of $0.0861 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3878 %, meaning that it generated $0.3878 on every $100 dollars invested by stockholders. BioRem's management efficiency ratios could be used to measure how well BioRem manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.1 in 2024. Return On Capital Employed is likely to climb to 0.32 in 2024. At this time, BioRem's Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 3.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.9 M in 2024.Similar Executives
Found 4 records | CHAIRMAN Age | ||
Jordan Grant | BluMetric Environmental | N/A | |
Irvin Thomas | Vitreous Glass | N/A | |
John Kelly | Thermal Energy International | N/A | |
Murray Malley | BluMetric Environmental | N/A |
Management Performance
Return On Equity | 0.39 | |||
Return On Asset | 0.0861 |
BioRem Inc Leadership Team
Elected by the shareholders, the BioRem's board of directors comprises two types of representatives: BioRem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioRem. The board's role is to monitor BioRem's management team and ensure that shareholders' interests are well served. BioRem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioRem's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dan Costello, Director Operations | ||
Robert Nally, Independent Director | ||
Anthony Ennis, Director | ||
Hadi Husain, VP of RandD | ||
Bernardo Llovera, Independent Chairman of the Board | ||
PEng MBA, President CEO | ||
Mark Smit, Director Services | ||
Derek Webb, Executive Vice President | ||
Brian Herner, Director | ||
Douglas Newman, CFO, Secretary |
BioRem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioRem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Pair Trading with BioRem
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioRem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioRem will appreciate offsetting losses from the drop in the long position's value.Moving together with BioRem Stock
0.61 | RY-PS | Royal Bank | PairCorr |
Moving against BioRem Stock
0.5 | TD | Toronto Dominion Bank | PairCorr |
The ability to find closely correlated positions to BioRem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioRem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioRem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioRem Inc to buy it.
The correlation of BioRem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioRem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioRem Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioRem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for BioRem Stock analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |